Skip to content

EMDR Treatment of Conditioned Nausea and Vomiting in Cancer Survivors

EMDR Treatment of Conditioned Nausea and Vomiting in Cancer Survivors - a Pilot Study

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06769165
Acronym
EMESIS
Enrollment
20
Registered
2025-01-10
Start date
2025-07-02
Completion date
2026-08-01
Last updated
2025-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer Survivors

Keywords

EMDR, Nausea, Vomiting

Brief summary

To explore the effectiveness of EMDR therapy treatment in reducing symptoms of chemotherapy-induced conditioned nausea and vomiting in (former) patients with cancer.

Detailed description

Conditioned nausea and vomiting is a common side effect of anti-cancer treatment, and while strategies like antiemetics exist, their effectiveness is limited. Conditioned nausea and vomiting can possibly be addressed through Eye Movement Desensitization and Reprocessing (EMDR) therapy. EMDR therapy is a therapeutic intervention, proven to be effective in the treatment of post-traumatic stress disorder (PTSD), and promising in treating a range of other conditions. At the UMCG, EMDR therapy is used on a small scale to treat conditioned nausea with positive results, although more rigorous research is needed to fully establish its efficacy. This study aims to explore the effectiveness of EMDR therapy treatment in reducing symptoms of chemotherapy-induced conditioned nausea and vomiting in (former) patients with cancer.

Interventions

In this study, EMDR therapy will be performed by psychologists of the UMCG who are trained in EMDR therapy and who have experience with patients with somatic diseases. In the EMDR therapy protocol, the patient is guided through eight phases which incorporate dual focus of attention and alternating bilateral visual, auditory, and/or tactile stimulation (see supplement for protocol). The number of sessions varies per patient (1-3 sessions), depending on the desensitization of the conditioned stimuli. The sessions will last 60-90 minutes.

Sponsors

University Medical Center Groningen
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
16 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Previously pathologically confirmed diagnosis of cancer * Previously treated with systemic cancer therapy * Persistent complaints (more than 2 months) of conditioned nausea and/or vomiting * Able to understand spoken and written Dutch * 18 years or older

Exclusion criteria

* Ongoing psychiatric treatment * EMDR therapy contraindications (dissociative disorders, personality disorders or severe somatic disorders (e.g. cardiac arrhythmias)) * Complex type 2 trauma * Known with recent conditions / non-anti-cancer medication which can elicit nausea (e.g. pregnancy or alcohol abuses)

Design outcomes

Primary

MeasureTime frameDescription
Degree of conditioned nausea and vomitingBefore intake EMDR therapy session and three weeks after last EMDR therapy sessionDegree of conditioned nausea and vomiting after exposure to conditioned stimuli using the nausea profile questionnaire measured using the nausea profile questionnaire (9-point Likert scale, higher scores = worse outcome)

Secondary

MeasureTime frameDescription
Impact on QoL of conditioned nausea and vomitingBefore EMDR therapyImpact on QoL of conditioned nausea and vomiting using Functional Living Index- Emesis (FLIE) questionnaire (7-point Likert scale, higher scores = better/worse outcome, depending on the question)

Countries

Netherlands

Contacts

Primary ContactJacco J de Haan, MD, PhD
j.j.de.haan@umcg.nl+31503616161

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026